首页> 外国专利> COMPOSITIONS CONTAINING COMPOUNDS HAVING RETINOID-LIKE ACTIVITY AND REDUCED SKIN TOXICITY EFFECTS AND SOME SUCH NOVEL COMPOUNDS

COMPOSITIONS CONTAINING COMPOUNDS HAVING RETINOID-LIKE ACTIVITY AND REDUCED SKIN TOXICITY EFFECTS AND SOME SUCH NOVEL COMPOUNDS

机译:含有具有类维甲酸活性,降低的皮肤毒性作用和某些新型化合物的化合物

摘要

A pharmaceutical composition for treating or preventing one or more of the diseases and conditions selected from the group consisting of dermatoses, malignant hyperproliferative diseases, atherosclerosis and restenosis resulting from neointimal hyperproliferation, non-malignant hyperproliferative diseases, autoimmune diseases, immunological disorders, chronic inflammatory diseases, diseases associated with lipid metabolism and transport such as dyslipidemias, dry eye syndrome, for promoting wound healing, and for reversing and preventing the effect of sun damage to skin, containing an effective dose of a compound of the formula 11 ז' באייר התשס" א - April 30, 2001 where the symbols are defined as follows: R1 is lower alkyl, Cl, Br, or I; R2 is H, lower alkyl, Cl, Br, or I; R3 is lower alkyl, Cl, Br, I, OR11, SR11, OCOR11, SCOR11, NH2, NHR11, N(R11)2, NHCOR11, or NR11- COR11; R5 and R6 independently are H, lower alkyl, Cl, Br, I, lower alkoxy or lower alkyltho of 1 to 6 carbons; B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR8, CONR9R10, -CH2OH, CH2OR11, CH2OCOR11, CHO, CH(OR12)2, CHOR13O, -COR7, CR7 (OR12)2, or CR7OR13O, where R7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R8 is an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R8 is phenyl or lower alkylphenyl, R9 and R10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or phenyl or lower alkylphenyl, R11 is alkyl of 1 to 10 carbons, phenyl or lower alkylphenyl, R12 is lower alkyl, and R13 is divalent alkyl radical of 2 - 5 carbons; X1 is CR5 or N, and in case X1 is N it can be located in any unsubstituted position of the 6-membered aromatic ring; Y is phenyl, thienyl, furyl, pyrrolyl, pyridyl, pyrimidyl, pyrazinyl, pyridazinyl, thiazolyl, imidazolyl and oxazolyl, with the proviso that when the compound has formula (I) then Y is not phenyl, A and Z are as defined in the specification, X1 is O, S, or NR15 and R15 is H or lower alkyl; the dashed circle in the 6 membered ring of formula (II) indicates the presence of two double bonds in the 5 membered ring, and X3 is O, S, NH or N-lower alkyl, and the X3 group can be located in any unsubstituted position of the 5-membered aromatic ring. Claimed as novel are the compounds of the formula: 12 ז' באייר התשס" א - April 30, 2001 where Y2 is thienyl, furyl or pyridyl; L1 and L2 are H or lower alkyl with the proviso that both are not H; or L1 and L2 jointly comprise -C(R20R20) - CH2-C (R20R20)-X4- and thereby form a heterocyclic ring condensed with the aromatic ring, or L1 and L2 jointly comprise - C(R20R20) - CH2-CH2-C(R20R20)- and thereby form a ring condensed with the aromatic ring; X4 is S, O, NH or N-lower alkyl, and R20 is independently H or lower alkyl, with the proviso that when L1 and L2 jointly comprise -C(R20R30) -CH2-CH2-C(R20R20) then Y2 is not phenyl.
机译:一种用于治疗或预防一种或多种疾病和病症的药物组合物,所述疾病和病症选自由新内膜过度增殖,非恶性过度增殖性疾病,自身免疫性疾病,免疫性疾病,慢性炎症性疾病引起的皮肤病,恶性过度增生性疾病,动脉粥样硬化和再狭窄。 ,与脂质代谢和运输有关的疾病,例如血脂异常,干眼综合征,促进伤口愈合,逆转和预防日晒对皮肤的影响,其中含有有效剂量的式11化合物א-2001年4月30日,其中符号定义如下:R1为低级烷基,Cl,Br或I; R2为H,低级烷基,Cl,Br或I; R3为低级烷基,Cl,Br,I ,OR11,SR11,OCOR11,SCOR11,NH2,NHR11,N(R11)2,NHCOR11或NR11-COR11; R5和R6独立为1的H,低级烷基,Cl,Br,I,低级烷氧基或低级烷基至6个碳; B是氢,COOH或其药学上可接受的盐,COOR8,CONR9R10,-CH2OH,CH2OR11,CH2OCOR11,CHO,CH(OR12)2,CHOR13O,-COR7,CR7(OR12)2或CR7OR13O,其中R7是烷基碳数为1至5的环烷基或烯基,R 8为碳数为1至10的烷基,或碳数为5至10的环烷基,或R 8为苯基或低级烷基苯基,R 9和R 10独立地为氢,烷基1-10个碳原子或5-10个碳原子的环烷基或苯基或低级烷基苯基,R11是1-10个碳原子的烷基,苯基或低级烷基苯基,R12是低级烷基,R13是2-的二价烷基5个碳; X 1是CR 5或N,并且如果X 1是N,则它可以位于6-元芳族环的任何未取代的位置; Y为苯基,噻吩基,呋喃基,吡咯基,吡啶基,嘧啶基,吡嗪基,哒嗪基,噻唑基,咪唑基和恶唑基,条件是当化合物具有式(I)时,Y不是苯基,则A和Z如式中所定义。规范中,X 1是O,S或NR 15,R 15是H或低级烷基;式(II)的6元环中的虚线圆圈表示在5元环中存在两个双键,并且X 3是O,S,NH或N-低级烷基,并且X 3基团可以位于任何未取代的基团中5元芳香环的位置。具有以下结构式的化合物被称为新化合物:12月31日-2001年4月30日,其中Y2是噻吩基,呋喃基或吡啶基; L1和L2是H或低级烷基,条件是它们都不是H;或L1 L 1和L 2共同包含-C(R 20 R 20)-CH 2 -C(R 20 R 20)-X 4-,从而形成与芳环稠合的杂环,或L 1和L 2共同包含-C(R 20 R 20)-CH 2 -CH 2 -C(R 20 R 20) )-并由此形成与芳环稠合的环; X4为S,O,NH或N-低级烷基,R20独立为H或低级烷基,条件是L1和L2共同构成-C(R20R30) -CH2-CH2-C(R20R20),则Y2不是苯基。

著录项

  • 公开/公告号IL105937B

    专利类型

  • 公开/公告日2001-04-30

    原文格式PDF

  • 申请/专利权人 ALLERGAN INC.;

    申请/专利号IL105937

  • 发明设计人

    申请日1993-06-07

  • 分类号A61K31/045;A61K31/095;A61K31/11;A61K31/12;A61K31/16;A61K31/335;A61K31/38;A61K31/395;A61P29/00;A61P37/00;

  • 国家 IL

  • 入库时间 2022-08-22 01:25:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号